A carregar...

Targeting angiogenesis in advanced cervical cancer

Patients with advanced stage or recurrent cervical cancer represent a population with limited chemotherapeutic options. More specifically, patients with recurrent disease have a poor salvage rate, with a 5-year survival rate of less than 10%. This year, the first prospective phase III clinical trial...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Eskander, Ramez N., Tewari, Krishnansu S.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4206649/
https://ncbi.nlm.nih.gov/pubmed/25364393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834014543794
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!